The bill aims to limit cost-sharing for epinephrine auto-injectors under health insurance policies and plans. It sets a cap on out-of-pocket expenses for patients requiring these life-saving devices. By reducing financial barriers, the bill seeks to ensure access to affordable epinephrine auto-injectors for individuals with severe allergies. This legislation would help alleviate the financial burden on patients and improve their ability to obtain necessary medication in emergency situations.
2024-02-02: Introduced
2024-02-02: Read first time and referred to Committee on Insurance
2024-02-07: Commissioner of Insurance report received pursuant to s.601.423(2), Wisconsin Statutes
2024-04-15: Failed to pass pursuant to Senate Joint Resolution 1
Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.
No Reviews found ..